Related Experiment Videos
[Current status of prostatic cancer screening]
1Servicio de Urología, Hospital General Universitario Vall d'Hebron, Barcelona.
Actas Urologicas Espanolas
|May 1, 1994
Summary
Prostate cancer screening is crucial due to new diagnostic tools like transrectal ultrasound and PSA tests. Early detection aims to reduce incidence and simplify diagnosis for symptomatic patients.
Area of Science:
- Urology
- Oncology
- Diagnostic Imaging
Context:
- Advancements in transrectal ultrasound and Prostate-Specific Antigen (PSA) testing enable earlier prostate cancer detection.
- Ongoing debate surrounds the benefits and risks of widespread prostate cancer screening programs.
Purpose:
- To discuss the implications of new diagnostic technologies for prostate cancer screening.
- To emphasize the importance of screening for early prostate cancer detection in symptomatic individuals.
Summary:
- Introduction of transrectal ultrasound and PSA testing facilitates the diagnosis of prostate tumors previously undetectable by digital rectal examination.
- Screening is presented as imperative for symptomatic patients, aiming to decrease disease incidence and simplify early-stage carcinoma detection.
Impact:
- Potential to significantly alter the approach to prostate cancer management and patient outcomes.
- Highlights the need for refined screening strategies to balance early detection benefits with potential harms.